SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
66<i>Rigel, Curis, Sonus, Cell Therapeutics, American Pharmaceutical The nkeokalani'nui-9/20/2002
65SOUTH SAN FRANCISCO, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Rigel Pharmaceutnigel bates-9/18/2002
64fwiw: White Mountain Capital Initiates Coverage and Rates Rigel a BUY PR Newmopgcw-9/5/2002
63Rigel and Daiichi Sign Agreement in New Field of Cancer Drug Discovery Deal is mopgcw-8/13/2002
62J Biol Chem 2002 Aug 2;277(31):28271-9 Related Articles, Books, LinkOut Amiskeokalani'nui-8/12/2002
61J Biol Chem 2002 Jul 11; [epub ahead of print] Related Articles, Books, LinkOut keokalani'nui-8/12/2002
60Rigel Announces Second Quarter 2002 Financial Results SOUTH SAN FRANCISCO, Calimopgcw-8/6/2002
59Scientific paper. First IND is likely to be the IGE signaling inhibitor (mast ckeokalani'nui-7/9/2002
58I'd thought there was a chance we would hear about an IND filing this summerMike McFarland-7/9/2002
57HCV program was supposed to be published this spring. Wonder what happened. Nokeokalani'nui-7/9/2002
56Rigel to Present Update on Hepatitis C Drug Development Program New Research Inmopgcw-7/9/2002
55the entire "Intellectual Property" section of the last 10-K.......... scaram(o)uche-6/25/2002
54Dane Pharmexa and U.S. Rigel settle patent dispute COPENHAGEN, June 24 (Reutermopgcw-6/25/2002
53>>RIGL wasn't heavy enough volume today to follow yesterday's GLFDtuck-6/21/2002
52Novel Celgene Ligase Inhibitors Regulate Key Cancer Pathways Additional Preclinikeokalani'nui-6/19/2002
51>> RIGL wasn't heavy enough volume today to follow yesterday's GLFscaram(o)uche-6/14/2002
50Further adventures in scalping . . . Had an order in for a bunch of shares atuck-6/14/2002
49>>SOUTH SAN FRANCISCO, Calif., May 22 /PRNewswire-FirstCall/ -- Rigel Phartuck-5/22/2002
48Libraria Partners With Rigel to Turn Genomic Targets Into Drugs Agreement Expandmopgcw-5/19/2002
47RIGL seems to be burning roughly 6 to 7 million per quarter. But that may acceltuck-5/7/2002
46>>SOUTH SAN FRANCISCO , Calif. -(Dow Jones)- Rigel Pharmaceuticals Inc. (Rtuck-5/6/2002
45Files to sell 17.4m on behalf of entities affiliated with Lombard, Odier & Ckeokalani'nui-4/30/2002
442002 AACR. 1811 A NOVEL APPROACH TO ISOLATE CELL CYCLE REGULATORS: FUNCTIONAL keokalani'nui-4/15/2002
43Tuesday April 9, 7:30 am Eastern Time Press Release SOURCE: Rigel Pharmaceuticalkeokalani'nui-4/9/2002
42Searching for comfort, this could be the beginning of a very nice chart: bigchakeokalani'nui-3/21/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News